Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Lawrence Corey, Peter B. Gilbert, Michal Juraska, +42

New England Journal of Medicine

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Peter B. Gilbert, Yunda Huang, Allan C. deCamp, +44

Nature Medicine

Phase Angle of Entrainment in Morning‐ and Evening‐Types under Naturalistic Conditions

Jonathan S. Emens, Krista Yuhas, Jennifer N. Rough, +3

Chronobiology International

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

Peter B. Gilbert, Michal Juraska, Allan C. deCamp, +27

Statistical Communications in Infectious Diseases

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

Jonathan D. Fuchs, Ian Frank, Marnie Elizaga, +32

Open Forum Infectious Diseases

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial

Marnie Elizaga, Shuying S. Li, Nidhi Kochar, +16

PLoS ONE

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8 ⁺ T-Cell Responses by Interleukin-12 Plasmid DNA

Shuying S. Li, Nidhi Kochar, Marnie Elizaga, +22

Clinical and Vaccine Immunology

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

Nyaradzo Mgodi, Simbarashe Takuva, Srilatha Edupuganti, +25

JAIDS Journal of Acquired Immune Deficiency Syndromes

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

Pierre‐Alexandre Bart, Yunda Huang, Shelly Karuna, +16

Journal of Clinical Investigation

Humoral ResponseImmunologyImmunodominancePriming DoseHuman Retrovirus +18

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody

Srilatha Edupuganti, Nyaradzo Mgodi, Shelly Karuna, +25

JAIDS Journal of Acquired Immune Deficiency Syndromes